C12N 2501/13
Nerve growth factor [ngf]
Official title: Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
C12N2501/13 (Nerve growth factor [ngf]) appears on 367 US grants and 725 published applications in this corpus.
Search patents in C12N- Granted patents
- 367
- Published applications
- 725
- Assignees
- 350
- Inventors
- 1,284
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 8 | 0 |
| 2001 | 3 | 1 |
| 2002 | 3 | 26 |
| 2003 | 11 | 19 |
| 2004 | 5 | 9 |
| 2005 | 4 | 27 |
| 2006 | 9 | 21 |
| 2007 | 4 | 19 |
| 2008 | 9 | 23 |
| 2009 | 9 | 17 |
| 2010 | 11 | 26 |
| 2011 | 5 | 19 |
| 2012 | 14 | 22 |
| 2013 | 11 | 26 |
| 2014 | 19 | 22 |
| 2015 | 15 | 28 |
| 2016 | 20 | 33 |
| 2017 | 16 | 24 |
| 2018 | 14 | 24 |
| 2019 | 21 | 46 |
| 2020 | 23 | 33 |
| 2021 | 9 | 33 |
| 2022 | 19 | 49 |
| 2023 | 12 | 42 |
| 2024 | 27 | 69 |
| 2025 | 22 | 42 |
| 2026 | 31 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Methods of differentiating neural cells and related compositions and methods of use15 Sep 2026US 12,734,196 B2Aspen Neuroscience, Inc.
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Nerve bundle and production method of nerve bundle9 Jun 2026US 12,649,901 B2University of Tsukuba
- Method and systems for innervating biofabricated tissues1 Oct 2026US 2026/0297513 A1University of Rochester
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
- Human ipsc derived ameloblasts and uses thereof10 Sep 2026US 2026/0265696 A1University of Washington
- Method for differentiating visceral sensory neurons from human induced pluripotent stem cells3 Sep 2026US 2026/0258351 A1Seoul National University R&Db Foundation
- Therapy3 Sep 2026US 2026/0258363 A1Plasticell Limited
Most cited
By later US patents
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006
- In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells145US 6,040,180 ANeuralStem Biopharmaceuticals, Ltd. · 2000
- Conditioned media for propagating human pluripotent stem cells145US 6,642,048 B2Geron Corporation · 2003